Our motivation at Hybrid Medical was to find a Peyronie’s disease (PD) treatment that could help men suffering from Acute phase/stage disease when PD is developing. Peyronie’s disease involves a cascade of events in which trauma leads to inflammation which leads to scar tissue development. Changing the natural course of this cascade was the focus of our research.
After nearly a decade of research, Hybrid Medical developed a Peyronie’s disease treatment that should target inflammation, scar tissue remodeling, and plaque development. As documented in prior independent studies, Nicardipine and Superoxide dismutase can accomplish this.2,3 To make sure these ingredients are delivered deep within the tissue, not just on the surface, we combined these ingredients with ultra-purified emu oil. It contains the fatty acids necessary to be an effective carrier agent.4,5,6 Emu oil also has been used for centuries by the Aborigines for scar tissue remodeling.
To verify that our scientific research was accurate, we performed a proof of concept/safety study that was double blind, randomized, and placebo-controlled. The results were very positive with statistical improvement in penile curvature, stretched penile length and pain reduction. Rash was the only side effect in about 10% of patients.
Our initial study size was relatively small, but its design was done under the guidance of Dr. Larry Levine, a world expert in Peyronie’s disease. Due to H100’s mechanism of action, the study only included acute phase patients with developing disease.
After the success of our research, we now offer the Peyronie’s disease treatment H100 to the public.
Hybrid Medical plans to continue clinical research on patients using H100 to assess improvement. One method of research will be from our Peyronie’s disease questionnaire (PDQ). This data will be published once it is gathered and analyzed. After filling out the questionnaire, patients will receive a $50 per month rebate on their H100 purchase.
Based on our study, maximum benefit was seen after six months of treatment with H100, though many patients noted improvement after three months of H100 Peyronie’s disease treatment.1 Every person reacts differently to different treatments. Patients usually try H100 for three months and, if you remain stable or improve, then continue for a total six months.
For best results, we recommend combining H100 use with a penile stretching/remodeling activity throughout your treatment.
For more helpful information and answers, please continue exploring our website.